Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2011

Open Access 01-12-2011 | Original investigation

Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents

Authors: Bruno Rodrigues, Kaleizu T Rosa, Alessandra Medeiros, Beatriz D Schaan, Patricia C Brum, Kátia De Angelis, Maria Cláudia Irigoyen

Published in: Cardiovascular Diabetology | Issue 1/2011

Login to get access

Abstract

Background

Although clinical diabetes mellitus is obviously a high risk factor for myocardial infarction (MI), in experimental studies disagreement exists about the sensitivity to ischemic injury of an infarcted myocardium. Recently, our group demonstrated that diabetic animals presented better cardiac function recovery and cellular resistance to ischemic injury than nondiabetics. In the present study, we evaluated the chronic effects of MI on left ventricular (LV) and autonomic functions in streptozotocin (STZ) diabetic rats.

Methods

Male Wistar rats were divided into 4 groups: control (C, n = 15), diabetes (D, n = 16), MI (I, n = 21), and diabetes + MI (DI, n = 30). MI was induced 15 days after diabetes (STZ) induction. Ninety days after MI, LV and autonomic functions were evaluated (8 animals each group). Left ventricular homogenates were analyzed by Western blotting to evaluate the expression of calcium handling proteins.

Results

MI area was similar in infarcted groups (~43%). Ejection fraction and +dP/dt were reduced in I compared with DI. End-diastolic pressure was additionally increased in I compared with DI. Compared with DI, I had increased Na+-Ca2+ exchange and phospholamban expression (164%) and decreased phosphorylated phospholamban at serine16 (65%) and threonine17 (70%) expression. Nevertheless, diabetic groups had greater autonomic dysfunction, observed by baroreflex sensitivity and pulse interval variability reductions. Consequently, the mortality rate was increased in DI compared with I, D, and C groups.

Conclusions

LV dysfunction in diabetic animals was attenuated after 90 days of myocardial infarction and was associated with a better profile of calcium handling proteins. However, this positive adaptation was not able to reduce the mortality rate of DI animals, suggesting that autonomic dysfunction is associated with increased mortality in this group. Therefore, it is possible that the better cardiac function has been transitory, and the autonomic dysfunction, more prominent in diabetic group, may lead, in the future, to the cardiovascular damage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM: Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ. 2001, 322: 1389-1393. 10.1136/bmj.322.7299.1389.PubMedCentralCrossRefPubMed Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM: Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ. 2001, 322: 1389-1393. 10.1136/bmj.322.7299.1389.PubMedCentralCrossRefPubMed
2.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed
3.
go back to reference Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997, 34: 113-120. 10.1016/S0008-6363(97)00037-0.CrossRefPubMed Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997, 34: 113-120. 10.1016/S0008-6363(97)00037-0.CrossRefPubMed
4.
go back to reference Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A, Styk J: Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia?. Basic Res Cardiol. 2001, 96 (2): 160-168. 10.1007/s003950170066.CrossRefPubMed Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A, Styk J: Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia?. Basic Res Cardiol. 2001, 96 (2): 160-168. 10.1007/s003950170066.CrossRefPubMed
5.
go back to reference Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, Lakkisto P, Mervaala E, Voipio-Pulkki LM, Laine M, Tikkanen I: Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia. 2004, 47 (2): 325-330.CrossRefPubMed Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, Lakkisto P, Mervaala E, Voipio-Pulkki LM, Laine M, Tikkanen I: Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia. 2004, 47 (2): 325-330.CrossRefPubMed
6.
go back to reference Liu Y, Thornton JD, Cohen MV, Downen JM, Schaffer SW: Streptozotocin-induced non-insulin dependent diabetes protect the heart from infarction. Circulation. 1993, 88: 1273-1278.CrossRefPubMed Liu Y, Thornton JD, Cohen MV, Downen JM, Schaffer SW: Streptozotocin-induced non-insulin dependent diabetes protect the heart from infarction. Circulation. 1993, 88: 1273-1278.CrossRefPubMed
7.
go back to reference Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhöffer A, Styk J: Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem. 2000, 210: 143-151. 10.1023/A:1007129708262.CrossRefPubMed Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhöffer A, Styk J: Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem. 2000, 210: 143-151. 10.1023/A:1007129708262.CrossRefPubMed
8.
go back to reference Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C, Sellke FW: Is hyperglycemia bad for the heart during acute ischemia?. J Thorac Cardiovasc Surg. 2010, 140: 1345-1352. 10.1016/j.jtcvs.2010.05.009.PubMedCentralCrossRefPubMed Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C, Sellke FW: Is hyperglycemia bad for the heart during acute ischemia?. J Thorac Cardiovasc Surg. 2010, 140: 1345-1352. 10.1016/j.jtcvs.2010.05.009.PubMedCentralCrossRefPubMed
9.
go back to reference Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC: Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010, 12 (7): 659-667. 10.1093/eurjhf/hfq053.CrossRefPubMed Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC: Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010, 12 (7): 659-667. 10.1093/eurjhf/hfq053.CrossRefPubMed
10.
go back to reference Schaffer SW, Croft CB, Solodushko V: Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol. 2000, 278 (6): H1948-54.PubMed Schaffer SW, Croft CB, Solodushko V: Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol. 2000, 278 (6): H1948-54.PubMed
11.
go back to reference Periasamy M, Bhupathy P, Babu GJ: Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res. 2008, 77 (2): 265-273. 10.1093/cvr/cvm056.CrossRefPubMed Periasamy M, Bhupathy P, Babu GJ: Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res. 2008, 77 (2): 265-273. 10.1093/cvr/cvm056.CrossRefPubMed
12.
go back to reference Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol. 2002, 283 (4): H1398-H1408.CrossRefPubMed Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol. 2002, 283 (4): H1398-H1408.CrossRefPubMed
13.
go back to reference Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, Curi R, Brum PC, Lacchini S, Montano N, De Angelis K, Irigoyen MC: Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J. Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, Curi R, Brum PC, Lacchini S, Montano N, De Angelis K, Irigoyen MC: Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J.
14.
go back to reference Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8 (6): e1000412-10.1371/journal.pbio.1000412.PubMedCentralCrossRefPubMed Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8 (6): e1000412-10.1371/journal.pbio.1000412.PubMedCentralCrossRefPubMed
15.
go back to reference Mostarda C, Rodrigues B, Vane M, Moreira ED, Rosa KT, Moraes-Silva IC, Lacchini S, Casarini DE, De Angelis K, Irigoyen MC: Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin Exp Pharmacol Physiol. 2010, 37 (4): 447-452. 10.1111/j.1440-1681.2009.05327.x.CrossRefPubMed Mostarda C, Rodrigues B, Vane M, Moreira ED, Rosa KT, Moraes-Silva IC, Lacchini S, Casarini DE, De Angelis K, Irigoyen MC: Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin Exp Pharmacol Physiol. 2010, 37 (4): 447-452. 10.1111/j.1440-1681.2009.05327.x.CrossRefPubMed
16.
go back to reference Wichi R, Malfitano C, Rosa K, De Souza SB, Salemi V, Mostarda C, De Angelis K, Irigoyen MC: Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol. 2007, 26: 6-14. Wichi R, Malfitano C, Rosa K, De Souza SB, Salemi V, Mostarda C, De Angelis K, Irigoyen MC: Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol. 2007, 26: 6-14.
17.
go back to reference Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, Casarini DE, Irigoyen MC, Krieger EM, Krieger JE, Negrão CE, Brum PC: Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol. 2008, 104 (1): 103-109. 10.1152/japplphysiol.00493.2007.CrossRefPubMed Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, Casarini DE, Irigoyen MC, Krieger EM, Krieger JE, Negrão CE, Brum PC: Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol. 2008, 104 (1): 103-109. 10.1152/japplphysiol.00493.2007.CrossRefPubMed
18.
go back to reference Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004, 141: 421-431.CrossRefPubMed Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004, 141: 421-431.CrossRefPubMed
19.
go back to reference Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559. 10.1056/NEJMoa0802743.CrossRef Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559. 10.1056/NEJMoa0802743.CrossRef
20.
go back to reference The ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572. 10.1056/NEJMoa0802987.CrossRef The ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572. 10.1056/NEJMoa0802987.CrossRef
21.
go back to reference Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056/NEJMoa0808431.CrossRefPubMed Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056/NEJMoa0808431.CrossRefPubMed
22.
go back to reference Vogel WM, Apstein CS: Effects of alloxan-induced diabetes on ischemia-reperfusion injury in rabbit hearts. Circ Res. 1988, 62 (5): 975-982.CrossRefPubMed Vogel WM, Apstein CS: Effects of alloxan-induced diabetes on ischemia-reperfusion injury in rabbit hearts. Circ Res. 1988, 62 (5): 975-982.CrossRefPubMed
23.
go back to reference Higuchi M, Ikema S, Sakanashi M: Correlation of contractile dysfunction and abnormal tissue energy metabolism during hypoperfusion with norepinephrine in isolated rat hearts: differences between normal and diabetic hearts. J Mol Cell Cardiol. 1992, 24 (10): 1125-1141. 10.1016/0022-2828(92)93177-L.CrossRefPubMed Higuchi M, Ikema S, Sakanashi M: Correlation of contractile dysfunction and abnormal tissue energy metabolism during hypoperfusion with norepinephrine in isolated rat hearts: differences between normal and diabetic hearts. J Mol Cell Cardiol. 1992, 24 (10): 1125-1141. 10.1016/0022-2828(92)93177-L.CrossRefPubMed
24.
go back to reference Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR: ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. 2000, 101 (17): 2090-2096.CrossRefPubMed Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR: ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. 2000, 101 (17): 2090-2096.CrossRefPubMed
25.
go back to reference King LM, Opie LH: Glucose and glycogen utilization in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol Cell Biochem. 1998, 180 (1-2): 3-26. 10.1023/A:1006870419309.CrossRefPubMed King LM, Opie LH: Glucose and glycogen utilization in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol Cell Biochem. 1998, 180 (1-2): 3-26. 10.1023/A:1006870419309.CrossRefPubMed
26.
go back to reference Ravingerova T, Neckar J, Kolar F: Ischemic tolerance of rat heart in acute and chronic phases of experimental diabetes. Mol Cell Biochem. 2003, 249: 167-174. 10.1023/A:1024751109196.CrossRefPubMed Ravingerova T, Neckar J, Kolar F: Ischemic tolerance of rat heart in acute and chronic phases of experimental diabetes. Mol Cell Biochem. 2003, 249: 167-174. 10.1023/A:1024751109196.CrossRefPubMed
27.
go back to reference Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z: Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol. 2004, 76 (1): 57-65. 10.1016/j.yexmp.2003.08.003.CrossRefPubMed Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z: Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol. 2004, 76 (1): 57-65. 10.1016/j.yexmp.2003.08.003.CrossRefPubMed
28.
go back to reference de Tombe PP: Altered contractile function in heart failure. Cardiovasc Res. 1998, 37: 367-380. 10.1016/S0008-6363(97)00275-7.CrossRefPubMed de Tombe PP: Altered contractile function in heart failure. Cardiovasc Res. 1998, 37: 367-380. 10.1016/S0008-6363(97)00275-7.CrossRefPubMed
29.
go back to reference Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E: Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res. 2005, 68 (3): 366-375. 10.1016/j.cardiores.2005.08.010.CrossRefPubMed Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E: Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res. 2005, 68 (3): 366-375. 10.1016/j.cardiores.2005.08.010.CrossRefPubMed
30.
go back to reference Tosaki A, Engelman DT, Engelman RM, Das DK: The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res. 1996, 31 (4): 526-536.CrossRefPubMed Tosaki A, Engelman DT, Engelman RM, Das DK: The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res. 1996, 31 (4): 526-536.CrossRefPubMed
31.
go back to reference Zorzano A, Sevilla L, Camps M, Becker C, Meyer J, Kammermeier H, Muñoz P, Gumà A, Testar X, Palacín M, Blasi J, Fischer Y: Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol. 1997, 80 (3A): 65A-76A. 10.1016/S0002-9149(97)00459-1.CrossRefPubMed Zorzano A, Sevilla L, Camps M, Becker C, Meyer J, Kammermeier H, Muñoz P, Gumà A, Testar X, Palacín M, Blasi J, Fischer Y: Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol. 1997, 80 (3A): 65A-76A. 10.1016/S0002-9149(97)00459-1.CrossRefPubMed
32.
go back to reference Belke DD, Larsen TS, Gibbs EM, Severson DL: Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol: Endocrinol Metab. 2000, 279 (5): E1104-E1113. Belke DD, Larsen TS, Gibbs EM, Severson DL: Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol: Endocrinol Metab. 2000, 279 (5): E1104-E1113.
33.
go back to reference DaTorre SD, Creer MH, Pogwizd SM, Corr PB: Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol. 1991, 23 (Suppl 1): 11-22. 10.1016/0022-2828(91)90019-I.CrossRefPubMed DaTorre SD, Creer MH, Pogwizd SM, Corr PB: Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol. 1991, 23 (Suppl 1): 11-22. 10.1016/0022-2828(91)90019-I.CrossRefPubMed
34.
go back to reference van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, van der Velden J, Boer C, Ouwens DM, Diamant M: Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol. 2009, 22: 8:39. van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, van der Velden J, Boer C, Ouwens DM, Diamant M: Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol. 2009, 22: 8:39.
35.
go back to reference Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003, 26 (6): 1895-1901. 10.2337/diacare.26.6.1895.CrossRefPubMed Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003, 26 (6): 1895-1901. 10.2337/diacare.26.6.1895.CrossRefPubMed
36.
go back to reference Mostarda C, Rogow A, Silva IC, De La Fuente RN, Jorge L, Rodrigues B, Heeren MV, Caldini EG, De Angelis K, Irigoyen MC: Benefits of exercise training in diabetic rats persist after three weeks of detraining. Auton Neurosci. 2009, 145 (1-2): 11-16. 10.1016/j.autneu.2008.10.010.CrossRefPubMed Mostarda C, Rogow A, Silva IC, De La Fuente RN, Jorge L, Rodrigues B, Heeren MV, Caldini EG, De Angelis K, Irigoyen MC: Benefits of exercise training in diabetic rats persist after three weeks of detraining. Auton Neurosci. 2009, 145 (1-2): 11-16. 10.1016/j.autneu.2008.10.010.CrossRefPubMed
37.
go back to reference Dall'ago P, D'Agord Schaan B, da Silva VO, Werner J, da Silva Soares PP, de Angelis K, Irigoyen MC: Parasympathetic dysfunction is associated with baroreflex and chemoreflex impairment in streptozotocin-induced diabetes in rats. Auton Neurosci. 2007, 131 (1-2): 28-35.CrossRefPubMed Dall'ago P, D'Agord Schaan B, da Silva VO, Werner J, da Silva Soares PP, de Angelis K, Irigoyen MC: Parasympathetic dysfunction is associated with baroreflex and chemoreflex impairment in streptozotocin-induced diabetes in rats. Auton Neurosci. 2007, 131 (1-2): 28-35.CrossRefPubMed
38.
go back to reference Shyu JF, Wang HS, Shyr YM, Wang SE, Chen CH, Tan JS, Lin MF, Hsieh PS, Sytwu HK, Chen TH: Alleviation of hyperglycemia in diabetic rats by intraportal injection of insulin-producing cells generated from surgically resected human pancreatic tissue. J Endocrinol. 2011, 208 (3): 233-244.PubMed Shyu JF, Wang HS, Shyr YM, Wang SE, Chen CH, Tan JS, Lin MF, Hsieh PS, Sytwu HK, Chen TH: Alleviation of hyperglycemia in diabetic rats by intraportal injection of insulin-producing cells generated from surgically resected human pancreatic tissue. J Endocrinol. 2011, 208 (3): 233-244.PubMed
Metadata
Title
Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents
Authors
Bruno Rodrigues
Kaleizu T Rosa
Alessandra Medeiros
Beatriz D Schaan
Patricia C Brum
Kátia De Angelis
Maria Cláudia Irigoyen
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2011
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-10-26

Other articles of this Issue 1/2011

Cardiovascular Diabetology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine